ALKERMES | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
J&J USD 71.55B 15.66B 2025-03
Malin Corporation EUR 35.9M 100K 2024-06
Merck USD 35.5B 3.28B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Otsuka Holdings JPY 1.32T 48.42B 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



ALKERMES Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.